Nabiximols, an oromucosal spray of a complete cannabis plant extract which has a one:1 ratio of THC to cannabidiol (CBD), was in the beginning licensed and accredited in Europe, the United Kingdom, and copyright to the therapy of pain and spasticity associated with multiple sclerosis (GW Prescription drugs, 2016; Pertwee, https://trafficaccidentclaims86306.blogsidea.com/39179218/the-best-side-of-cannabis-flower